Ultrasound features like size ≥10 mm and vascularity associate with neoplastic gallbladder polyps in meta-analysis

This systematic review and meta-analysis evaluated the diagnostic accuracy of ultrasound imaging features for distinguishing neoplastic from non-neoplastic gallbladder polyps. The study design involved a comprehensive synthesis of 30 observational studies, encompassing a total population of 8,953 patients with gallbladder polyps. The setting was not reported, but the analysis focused on data from multiple centers, aiming to aggregate evidence on ultrasound characteristics. The population consisted of individuals diagnosed with gallbladder polyps, with no specific demographic details provided, reflecting a broad clinical sample across the included studies.

The intervention or exposure was ultrasound imaging features, assessed as diagnostic markers, with the comparator being the differentiation between neoplastic and non-neoplastic polyps. There were no medications or specific dosing protocols involved, as the analysis centered on imaging parameters. The primary outcome was diagnostic odds ratios (DORs), sensitivities, and specificities for various ultrasound features in diagnosing neoplastic polyps. Key findings included significant associations for multiple features: size ≥10 mm had a DOR of 6.23 (95% CI: 1.86-20.90), sessile morphology a DOR of 3.54 (95% CI: 1.93-5.97), single polyp a DOR of 2.21 (95% CI: 1.76-2.74), coexisting gallstones a DOR of 1.86 (95% CI: 1.29-2.60), hypoechogenicity a DOR of 3.55 (95% CI: 1.47-7.30), gallbladder wall thickening (GBWT) a DOR of 9.38 (95% CI: 1.47-32.20), absence of hyperechoic spots a DOR of 4.23 (95% CI: 2.46-6.83), and vascularity a DOR of 9.72 (95% CI: 5.81-15.30). All these associations were positive and statistically significant based on confidence intervals not crossing 1.

In terms of diagnostic performance, size ≥10 mm demonstrated the highest pooled sensitivity at 0.79 (95% CI: 0.68-0.87), while hypoechogenicity showed the highest pooled specificity at 0.93 (95% CI: 0.82-0.98). These results provide quantitative estimates of how well these ultrasound features can identify neoplastic polyps, with vascularity and GBWT showing particularly high DORs, indicating strong associations. No secondary outcomes were reported in the input, so the analysis is limited to these primary diagnostic metrics.

Safety and tolerability findings were not reported in the input, as the study focused on diagnostic accuracy rather than intervention-related adverse events. This absence highlights that the meta-analysis does not address risks associated with ultrasound use or subsequent management decisions, which are typically low for imaging procedures but should be considered in clinical practice.

Comparing these results to prior landmark studies in this therapeutic area is challenging due to the lack of specific references in the input. However, this meta-analysis aggregates data from 30 studies, potentially offering a more robust synthesis than individual observational reports. It aligns with existing literature suggesting that features like size and morphology are key in polyp assessment, but the high DORs for vascularity and GBWT may underscore emerging evidence on their importance.

Key methodological limitations include the observational nature of the included studies, which precludes causal inferences, as noted in the input. Potential biases such as selection bias, heterogeneity in ultrasound techniques across studies, and publication bias are not detailed but are inherent in meta-analyses of observational data. The use of bivariate random-effects models helps address some heterogeneity, but residual confounding may affect the pooled estimates. The input explicitly cautions that associations do not imply causation and that imaging features are surrogates, not direct clinical outcomes.

Clinical implications suggest that ultrasound features like size ≥10 mm, vascularity, and hypoechogenicity may facilitate the management of gallbladder polyps by aiding in risk stratification for neoplastic potential. However, clinicians should use these findings as adjunctive tools, integrating them with clinical judgment and considering factors like patient symptoms and comorbidities. The high specificity of hypoechogenicity could help rule in neoplastic polyps, while the sensitivity of size ≥10 mm might support surveillance or further evaluation in ambiguous cases.

Unanswered questions include the optimal combination of ultrasound features for clinical decision-making, the impact of patient demographics on diagnostic accuracy, and long-term outcomes based on these imaging markers. Future research should focus on prospective studies to validate these associations and explore their utility in guiding interventions like cholecystectomy, as well as assessing cost-effectiveness and patient-centered outcomes.